New Drug Development Pipeline

At Biozipcode, Inc., we have completed the basic research for a curative diabetes treatment drug (repositioning) and a diabetes treatment drug for pets. Furthermore, in the case of repositioning, since the existing drug has already been confirmed for safety and pharmacokinetics in humans, there is a possibility that Phase 1 trials, which test safety and pharmacokinetics in healthy adults, may not be necessary. We believe this could significantly reduce the development time and costs, which are generally considered to exceed 10 years for new drugs.

Related Information

We are currently creating detailed documentation regarding the details of the pipeline.

Are you interested in our business?

Are you interested in our business?

Medical professionals, investors, and members of the press, please feel free to contact us by filling out the necessary information in the email form. Our representatives will get back to you promptly.

Medical professionals, investors, and members of the press, please feel free to contact us by filling out the necessary information in the email form. Our representatives will get back to you promptly.